
Eligo Bioscience has entered into a research and option agreement with GlaxoSmithKline (GSK) aimed at advancing Eligobiotics for the treatment …

British multinational GlaxoSmithKline has announced the closure of its manufacturing facilities in Sligo, Ireland. The company is set to wind …

GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

